![Frederic Roch Doliveux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederic Roch Doliveux
Président chez
OXFORD BIOMEDICA PLC
Fortune : 4 M $ au 31/05/2026
Profil
Le Dr Frederic Roch Doliveux est président non exécutif d'Oxford Biomedica Plc, président du Caring Entrepreneurship Fund, président de Pierre Fabre SA et membre du Conseil international de l'INSEAD. Il est membre du conseil d'administration d'UCB SA, de la Vlerick Leuven Gent Management School, de Vlerick Research NV, de la Biotechnology Innovation Organization, de Pierre Fabre Participations SASU, du Science & Business Innovation Board et du Wallon Institute for Life Lead Sciences. Le Dr Doliveux a été précédemment employé en tant que président par GLG Healthcare Institute, directeur indépendant par Stryker Corp, directeur général et directeur exécutif par UCB SA, président par Schering-Plough Corp, président par Schering-Plough International, Inc, vice-président par European Federation of Pharmaceutical Industries & Assns, directeur général par Pierre Fabre Pharmaceuticals, Inc, et président par The Innovative Medicines Initiative. Il est titulaire d'un MBA de l'INSEAD et d'un doctorat de l'École Nationale Vtrinaire d'Alfort.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0,36 % | 31/12/2025 | 438 805 ( 0,36 % ) | 4 M $ | 31/05/2026 |
Postes actifs de Frederic Roch Doliveux
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD BIOMEDICA PLC | Président | 24/06/2020 |
Vlerick Research NV
 Vlerick Research NV Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Directeur/Membre du Conseil | 01/11/2012 |
Pierre Fabre Participations SAS
 Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology and cosmetic products | Directeur/Membre du Conseil | 24/07/2019 |
Caring Entrepreneurship Fund | Président | 01/01/2009 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Wallon Institute for Life Lead Sciences | Directeur/Membre du Conseil | 14/09/2010 |
Science & Business Innovation Board | Directeur/Membre du Conseil | 14/09/2010 |
INSEAD International Council | Corporate Officer/Principal | 15/03/2012 |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Président | 01/05/2017 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Frederic Roch Doliveux
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Frederic Roch Doliveux
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Stryker Corp.
 Stryker Corp. Medical SpecialtiesHealth Technology Manufactures and markets reconstructive, medical and surgical, and neurotechnology and spine products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology and cosmetic products | Health Technology |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
 Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Chiesi Ltd.
 Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Health Technology |
École Nationale Vétérinaire d'Alfort
 École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD International Council | |
Science & Business Innovation Board | |
Wallon Institute for Life Lead Sciences | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade Operates as pharmaceutical industry | Retail Trade |
Schering-Plough International, Inc.
 Schering-Plough International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceuticals and health care products | Health Technology |
Caring Entrepreneurship Fund | |
GLG Healthcare Institute
 GLG Healthcare Institute Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Vlerick Research NV
Vlerick Research NV Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Pierre Fabre Pharmaceuticals, Inc.
 Pierre Fabre Pharmaceuticals, Inc. Medical DistributorsDistribution Services Part of Pierre Fabre Participations SAS, Pierre Fabre Pharmaceuticals, Inc. is a company that specializes in Hemangeol®, an FDA-approved oral treatment for proliferating infantile hemangioma, a common benign vascular tumor in infants. The company is based in Parsippany, NJ. Hemangeol contains propranolol hydrochloride, a beta-blocker formulated for infants aged 5 weeks to 5 months, and is administered twice daily for about six months. The medication is alcohol-, sugar-, and paraben-free, flavored strawberry-vanilla, and comes with a child-resistant bottle and dosing syringe. The company provides resources for parents, caregivers, pharmacists, and healthcare professionals, including caregiver guides, dosing calculators, a digital app for treatment adherence, physician discussion guides, educational materials, and a co-pay savings program. Safety information includes contraindications for certain infants and potential side effects. | Distribution Services |
